메뉴 건너뛰기




Volumn 24, Issue 13, 2006, Pages 2283-2289

Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague

Author keywords

Pneumonic plague; Respiratory immunity; Subunit vaccine

Indexed keywords

HYBRID PROTEIN; RECOMBINANT F1 V PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

EID: 33344455205     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.047     Document Type: Article
Times cited : (18)

References (30)
  • 1
    • 0034600229 scopus 로고    scopus 로고
    • Plague as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense
    • T.V. Inglesby, D.T. Dennis, and D.A. Henderson Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense Jama 283 17 2000 2281 2290
    • (2000) Jama , vol.283 , Issue.17 , pp. 2281-2290
    • Inglesby, T.V.1    Dennis, D.T.2    Henderson, D.A.3
  • 3
    • 0031029062 scopus 로고    scopus 로고
    • Yersinia pestis - Etiologic agent of plague
    • R.D. Perry, and J.D. Fetherston Yersinia pestis - etiologic agent of plague Clin Microbiol Rev 10 1 1997 35 66
    • (1997) Clin Microbiol Rev , vol.10 , Issue.1 , pp. 35-66
    • Perry, R.D.1    Fetherston, J.D.2
  • 4
    • 3843148925 scopus 로고    scopus 로고
    • Possession, use, and transfer of select agents and toxins. Interim final rule
    • Possession, use, and transfer of select agents and toxins. Interim final rule Fed Regist 67 240 2002 76886 76905
    • (2002) Fed Regist , vol.67 , Issue.240 , pp. 76886-76905
  • 5
    • 0016064258 scopus 로고
    • Plague immunization. V. Indirect evidence for the efficacy of plague vaccine
    • D.C. Cavanaugh, B.L. Elisberg, and C.H. Llewellyn Plague immunization. V. Indirect evidence for the efficacy of plague vaccine J Infect Dis 129 Suppl 1974 S37 S40
    • (1974) J Infect Dis , vol.129 , Issue.SUPPL.
    • Cavanaugh, D.C.1    Elisberg, B.L.2    Llewellyn, C.H.3
  • 6
    • 14244252033 scopus 로고    scopus 로고
    • Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens
    • A. Glynn, L.C. Freytag, and J.D. Clements Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens Vaccine 23 16 2005 1957 1965
    • (2005) Vaccine , vol.23 , Issue.16 , pp. 1957-1965
    • Glynn, A.1    Freytag, L.C.2    Clements, J.D.3
  • 7
    • 0035919586 scopus 로고    scopus 로고
    • Vaccination against bubonic and pneumonic plague
    • R.W. Titball, and E.D. Williamson Vaccination against bubonic and pneumonic plague Vaccine 19 30 2005 4175 4184
    • (2005) Vaccine , vol.19 , Issue.30 , pp. 4175-4184
    • Titball, R.W.1    Williamson, E.D.2
  • 9
    • 0031750789 scopus 로고    scopus 로고
    • Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
    • D.G. Heath, G.W. Anderson Jr., and J.M. Mauro Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine Vaccine 16 11-12 1998 1131 1137
    • (1998) Vaccine , vol.16 , Issue.11-12 , pp. 1131-1137
    • Heath, D.G.1    Anderson Jr., G.W.2    Mauro, J.M.3
  • 10
    • 2642647115 scopus 로고    scopus 로고
    • Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice
    • G.W. Anderson Jr., D.G. Heath, C.R. Bolt, S.L. Welkos, and A.M. Friedlander Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice Am J Trop Med Hyg 58 6 1998 793 799
    • (1998) Am J Trop Med Hyg , vol.58 , Issue.6 , pp. 793-799
    • Anderson Jr., G.W.1    Heath, D.G.2    Bolt, C.R.3    Welkos, S.L.4    Friedlander, A.M.5
  • 11
    • 0342424907 scopus 로고    scopus 로고
    • A recombinant capsular F1-V antigen fusion protein vaccine protects against experimental bubonic and pneumonic plague
    • Cold Spring Harbor Laboratory Press
    • D. Heath, G.W. Anderson Jr., S.L. Welkos, G.P. Andrews, and A.M. Friedlander A recombinant capsular F1-V antigen fusion protein vaccine protects against experimental bubonic and pneumonic plague Vaccines 97 1997 Cold Spring Harbor Laboratory Press p. 197-200
    • (1997) Vaccines 97
    • Heath, D.1    Anderson Jr., G.W.2    Welkos, S.L.3    Andrews, G.P.4    Friedlander, A.M.5
  • 12
    • 0030740115 scopus 로고    scopus 로고
    • A subunit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague
    • E.D. Williamson, S.M. Eley, A.J. Stagg, M. Green, P. Russell, and R.W. Titball A subunit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague Vaccine 15 10 1997 1079 1084
    • (1997) Vaccine , vol.15 , Issue.10 , pp. 1079-1084
    • Williamson, E.D.1    Eley, S.M.2    Stagg, A.J.3    Green, M.4    Russell, P.5    Titball, R.W.6
  • 13
    • 0030464421 scopus 로고    scopus 로고
    • Local and systemic immune response to a microencapsulated subunit vaccine for plague
    • E.D. Williamson, G.J. Sharp, and S.M. Eley Local and systemic immune response to a microencapsulated subunit vaccine for plague Vaccine 14 17-18 1996 1613 1619
    • (1996) Vaccine , vol.14 , Issue.17-18 , pp. 1613-1619
    • Williamson, E.D.1    Sharp, G.J.2    Eley, S.M.3
  • 14
    • 10244256319 scopus 로고    scopus 로고
    • Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis
    • G.W. Anderson Jr., S.E. Leary, and E.D. Williamson Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis Infect Immun 64 11 1996 4580 4585
    • (1996) Infect Immun , vol.64 , Issue.11 , pp. 4580-4585
    • Anderson Jr., G.W.1    Leary, S.E.2    Williamson, E.D.3
  • 15
    • 0029993925 scopus 로고    scopus 로고
    • Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge
    • G.P. Andrews, D.G. Heath, G.W. Anderson Jr., S.L. Welkos, and A.M. Friedlander Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge Infect Immun 64 6 1996 2180 2187
    • (1996) Infect Immun , vol.64 , Issue.6 , pp. 2180-2187
    • Andrews, G.P.1    Heath, D.G.2    Anderson Jr., G.W.3    Welkos, S.L.4    Friedlander, A.M.5
  • 16
    • 0029134827 scopus 로고
    • Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague
    • S.E. Leary, E.D. Williamson, K.F. Griffin, P. Russell, S.M. Eley, and R.W. Titball Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague Infect Immun 63 8 1995 2854 2858
    • (1995) Infect Immun , vol.63 , Issue.8 , pp. 2854-2858
    • Leary, S.E.1    Williamson, E.D.2    Griffin, K.F.3    Russell, P.4    Eley, S.M.5    Titball, R.W.6
  • 17
    • 0002335252 scopus 로고
    • Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis
    • K.F. Meyer, J.A. Hightower, and F.R. McCrumb Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis J Infect Dis 129 Suppl 1974 S41 S45
    • (1974) J Infect Dis , vol.129 , Issue.SUPPL.
    • Meyer, K.F.1    Hightower, J.A.2    McCrumb, F.R.3
  • 18
    • 0015910427 scopus 로고
    • Clinical and serological responses to plague vaccine U.S.P.
    • P.J. Bartelloni, J.D. Marshall Jr., and D.C. Cavanaugh Clinical and serological responses to plague vaccine U.S.P. Military Med 138 1973 720 722
    • (1973) Military Med , vol.138 , pp. 720-722
    • Bartelloni, P.J.1    Marshall Jr., J.D.2    Cavanaugh, D.C.3
  • 19
    • 0029021978 scopus 로고
    • Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization
    • R. Nakajima, V.L. Motin, and R.R. Brubaker Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization Infect Immun 63 8 1995 3021 3029
    • (1995) Infect Immun , vol.63 , Issue.8 , pp. 3021-3029
    • Nakajima, R.1    Motin, V.L.2    Brubaker, R.R.3
  • 20
    • 0032833608 scopus 로고    scopus 로고
    • Virulence role of V antigen of Yersinia pestis at the bacterial surface
    • K.A. Fields, M.L. Nilles, C. Cowan, and S.C. Straley Virulence role of V antigen of Yersinia pestis at the bacterial surface Infect Immun 67 10 1999 5395 5408
    • (1999) Infect Immun , vol.67 , Issue.10 , pp. 5395-5408
    • Fields, K.A.1    Nilles, M.L.2    Cowan, C.3    Straley, S.C.4
  • 21
    • 0027534069 scopus 로고
    • Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha
    • R. Nakajima, and R.R. Brubaker Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha Infect Immun 61 1 1993 23 31
    • (1993) Infect Immun , vol.61 , Issue.1 , pp. 23-31
    • Nakajima, R.1    Brubaker, R.R.2
  • 23
    • 0033047173 scopus 로고    scopus 로고
    • Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice
    • G.E. Benner, G.P. Andrews, and W.R. Byrne Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice Infect Immun 67 4 1999 1922 1928
    • (1999) Infect Immun , vol.67 , Issue.4 , pp. 1922-1928
    • Benner, G.E.1    Andrews, G.P.2    Byrne, W.R.3
  • 24
    • 0033805905 scopus 로고    scopus 로고
    • Adjuvant activity of monophosphoryl lipid a for nasal and oral immunization with soluble or liposome-associated antigen
    • N.K. Childers, K.L. Miller, and G. Tong Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen Infect Immun 68 10 2000 5509 5516
    • (2000) Infect Immun , vol.68 , Issue.10 , pp. 5509-5516
    • Childers, N.K.1    Miller, K.L.2    Tong, G.3
  • 25
    • 0028689539 scopus 로고
    • Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes
    • T.M. McHugh Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes Methods Cell Biol 42 Pt B 1994 575 595
    • (1994) Methods Cell Biol , vol.42 , Issue.PART B , pp. 575-595
    • McHugh, T.M.1
  • 26
    • 0034012994 scopus 로고    scopus 로고
    • Monophosphoryl lipid a enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
    • J.R. Baldridge, Y. Yorgensen, J.R. Ward, and J.T. Ulrich Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration Vaccine 18 22 2000 2416 2425
    • (2000) Vaccine , vol.18 , Issue.22 , pp. 2416-2425
    • Baldridge, J.R.1    Yorgensen, Y.2    Ward, J.R.3    Ulrich, J.T.4
  • 27
    • 0028058806 scopus 로고
    • Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide
    • V.L. Motin, R. Nakajima, G.B. Smirnov, and R.R. Brubaker Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide Infect Immun 62 10 1994 4192 4201
    • (1994) Infect Immun , vol.62 , Issue.10 , pp. 4192-4201
    • Motin, V.L.1    Nakajima, R.2    Smirnov, G.B.3    Brubaker, R.R.4
  • 28
    • 1842369046 scopus 로고    scopus 로고
    • Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis
    • G.W. Anderson Jr., P.L. Worsham, and C.R. Bolt Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis Am J Trop Med Hyg 56 4 1997 471 473
    • (1997) Am J Trop Med Hyg , vol.56 , Issue.4 , pp. 471-473
    • Anderson Jr., G.W.1    Worsham, P.L.2    Bolt, C.R.3
  • 29
    • 5344253042 scopus 로고    scopus 로고
    • Stat 4 but not Stat 6-mediated immune mechanisms are essential in protection against plague
    • S.J. Elvin, and E.D. Williamson Stat 4 but not Stat 6-mediated immune mechanisms are essential in protection against plague Microb Pathog 37 4 2004 177 184
    • (2004) Microb Pathog , vol.37 , Issue.4 , pp. 177-184
    • Elvin, S.J.1    Williamson, E.D.2
  • 30
    • 16244404901 scopus 로고    scopus 로고
    • Yersinia pestis V protein epitopes recognized by CD4 T cells
    • M.A. Parent, K.N. Berggren, and I.K. Mullarky Yersinia pestis V protein epitopes recognized by CD4 T cells Infect Immun 73 4 2005 2197 2204
    • (2005) Infect Immun , vol.73 , Issue.4 , pp. 2197-2204
    • Parent, M.A.1    Berggren, K.N.2    Mullarky, I.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.